Loading viewer...
investor_presentation
Format: PDF investor_presentation
RxSight presents its adjustable premium intraocular lens (IOL) technology and market positioning in the ophthalmology sector. The presentation covers the company's addressable market opportunity, IOL innovation trends over 60 years, and adoption projections for premium IOLs in cataract surgical procedures. RxSight outlines its competitive positioning and growth strategy in the global IOL market.
investor_presentation
investor_presentation
20 Pages
BriaCell Therapeutics Corp.
investor_presentation
Bosch Group